Chinook Investment Partners backs veterinary infusion supplier PractiVet

By AI, Created 3:40 PM UTC, May 20, 2026, /AGP/ – Chinook Investment Partners completed a growth investment in PractiVet on April 29, 2026, giving the veterinary devices supplier fresh support as it expands product innovation and channel reach. The deal keeps PractiVet under its existing brand and leadership while adding a board member and outside financing partners.

Why it matters: - PractiVet serves a large base of veterinary hospitals, clinics and universities with infusion devices and IV consumables used in critical care settings. - The investment could help expand product development and distribution in the animal health market. - Chinook is betting on a niche sector where clinical workflow, safety and reliability can directly affect patient care and operating efficiency.

What happened: - Chinook Investment Partners completed a growth investment in PractiVet on April 29, 2026. - Chinook is a Colorado-based equity capital partner focused on founder- and management-led businesses. - PractiVet is a branded supplier of veterinary infusion devices, syringe pump devices and IV infusion set consumables. - The transaction was announced May 20, 2026. - PractiVet will continue to operate under its existing brand and leadership.

The details: - PractiVet was founded in 2007. - The company says it supports thousands of veterinary hospitals and universities across the U.S. - PractiVet has more than 30,000 infusion devices deployed across specialty, emergency and academic veterinary settings. - The company’s product offerings are designed to improve clinical outcomes, safety procedures and workflow for veterinarians, technicians and pet patients. - Chinook expects the partnership to accelerate product innovation, strategic channel expansion and selective investment opportunities within animal health. - The investment terms were not disclosed. - Chinook was supported by Mercantile Bank, Charter Growth Capital and other equity co-investors. - Lincoln International assisted Chinook on the transaction. - McGuireWoods LLP served as legal counsel to Chinook. - Dorsey & Whitney LLP served as legal counsel to PractiVet. - Chinook and PractiVet said veterinary industry veteran Anthony Providenti joined the company’s board. - PractiVet said its devices and IV set products are trusted by leading specialty hospitals, emergency clinics, general practice clinics and veterinary teaching institutions across the U.S. - More information on PractiVet - More information on Chinook Investment Partners

Between the lines: - Chinook is backing a business with an installed base already embedded in veterinary care workflows, which can make growth more durable than a pure-startup model. - The addition of an industry veteran to the board suggests the investors want more operating depth as PractiVet pushes for scale. - Chinook framed the deal as part of a broader thesis around long-term demand in animal health.

What’s next: - PractiVet will keep pursuing its goal of becoming a leading supplier of veterinary infusion and critical care medical solutions. - The partnership is expected to support future product launches and broader commercial reach. - Both sides said they will work to expand quality of care, clinical outcomes and cost savings across the animal health value chain.